At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- Evaluating the analytical performance of direct-to-consumer gut microbiome testing services (Nature)
- Resecting a Rectal Carcinoid (GI & Endoscopy News)
- AI blood test detects early pancreatic cancer with up to 94% accuracy (Medical Xpress)
- Why 2026 is a reset year for U.S. health care (Medical Economics)
- The “Dream Team” for Managing IBS-C Needs GI Psychologist and Dietician (Gastroenterology Learning Network)
- March 2026 issue Of The American Journal of Gastroenterology (The American Journal of Gastroenterology)
- The GI physician shortage by state, by 2036 (Becker’s GI & Endoscopy)
- PAGI Joins UPMC to Expand Access to Specialized Gastroenterology Care in Central Pa. (UPMC)
